IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?
- PMID: 11577168
- PMCID: PMC1187083
- DOI: 10.1136/mp.54.5.285
IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?
Abstract
Insulin-like growth factors (IGFs), IGF receptors, and IGF binding proteins (IGFBPs) constitute the IGF system. Comprehensive data indicate that these factors play a pivotal role in tumorigenesis. Epidemiological data indicate that cancer risk is associated with high serum IGF-I values. Because dysregulation of the IGF system is a frequent pattern in malignancy, IGFs/IGFBPs might represent novel tumour markers that could be useful both for diagnosis and surveillance.
Similar articles
-
Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells.Int J Urol. 1996 Jan;3(1):39-46. doi: 10.1111/j.1442-2042.1996.tb00628.x. Int J Urol. 1996. PMID: 8646598
-
Nutritional regulation of circulating insulin-like growth factors (IGFs) and their binding proteins in the ovine fetus.Endocr J. 1997 Feb;44(1):163-73. doi: 10.1507/endocrj.44.163. Endocr J. 1997. PMID: 9152630
-
Insulin-Like Growth Factor Signaling in Alzheimer's Disease: Pathophysiology and Therapeutic Strategies.Mol Neurobiol. 2025 Mar;62(3):3195-3225. doi: 10.1007/s12035-024-04457-1. Epub 2024 Sep 6. Mol Neurobiol. 2025. PMID: 39240280 Free PMC article. Review.
-
Ontogeny of IGFs and IGFBPs mRNA levels and tissue concentrations in liver, kidney and skeletal muscle of pig.Growth Dev Aging. 1996 Autumn-Winter;60(3-4):171-87. Growth Dev Aging. 1996. PMID: 9007568
-
The insulin-like growth factor system and cancer.Cancer Lett. 2003 Jun 10;195(2):127-37. doi: 10.1016/s0304-3835(03)00159-9. Cancer Lett. 2003. PMID: 12767520 Review.
Cited by
-
The effects of Berberis vulgaris consumption on plasma levels of IGF-1, IGFBPs, PPAR-γ and the expression of angiogenic genes in women with benign breast disease: a randomized controlled clinical trial.BMC Complement Altern Med. 2019 Nov 21;19(1):324. doi: 10.1186/s12906-019-2715-1. BMC Complement Altern Med. 2019. PMID: 31752829 Free PMC article. Clinical Trial.
-
Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.PLoS One. 2008;3(11):e3661. doi: 10.1371/journal.pone.0003661. Epub 2008 Nov 6. PLoS One. 2008. PMID: 18987750 Free PMC article.
-
Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer.Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5563-8. doi: 10.1073/pnas.0609139104. Epub 2007 Mar 19. Proc Natl Acad Sci U S A. 2007. PMID: 17372210 Free PMC article.
-
IGFBP-3 inhibits Wnt signaling in metastatic melanoma cells.Mol Carcinog. 2017 Feb;56(2):681-693. doi: 10.1002/mc.22525. Epub 2016 Jul 27. Mol Carcinog. 2017. PMID: 27377812 Free PMC article.
-
Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivo.PLoS One. 2014 Jun 6;9(6):e98641. doi: 10.1371/journal.pone.0098641. eCollection 2014. PLoS One. 2014. PMID: 24905466 Free PMC article.
References
-
- Baserga R. The insulin-like growth factor receptor: a key to tumor growth? Cancer Res 1995;55:249–52. - PubMed
-
- Werner H, LeRoith D. The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 1996;68:183–223. - PubMed
-
- Werner H, LeRoith D. The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis. Crit Rev Oncog 1997;8:71–92. - PubMed
-
- Clemmons DR. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol 1998;140:19–24. - PubMed
-
- Bergmann U, Funatomi H, Yokoyama M, et al. Insulin-like growth factor-I-receptors overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 1995;55:2007–11. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources